Supplements, diets and protocols: what the evidence says
Five common claims about multiple sclerosis, diets and supplements, checked against human studies and safety evidence.
Guide reviewed: 30 October 2026. K2 and B12 absorption addition reviewed: 3 November 2026.
This page explains evidence; it is not medical advice. It gives no doses or brands.
Vitamin D
In plain words: Correct vitamin D deficiency; as MS treatment, trial results are mixed and it does not replace prescribed care.
Randomised trials with mixed results
What is claimed
Low vitamin D causes multiple sclerosis, so supplements can prevent, control or reverse it.
What human studies show
- Before symptoms, an observational study linked higher vitamin D with lower later MS risk in one subgroup; it neither tested supplements nor proved causation.[1]
- D-Lay MS randomised 316 people with a first episode suggestive of MS or very early disease. Over 24 months, its main goal—relapse or new MRI activity—occurred in 94/156 (60.3%) with vitamin D and 109/147 (74.1%) with placebo. Relapse alone was not significantly reduced; it did not compare with established MS treatment.[2]
- In established relapsing MS, VIDAMS found no significant difference in confirmed relapses between higher and lower vitamin D alongside prescribed treatment. SOLAR also missed its main goal; both differ from D-Lay.[3], [4]
Risks
Excess vitamin D can raise calcium levels and harm the kidneys; some medicines can increase that risk. Monitored trial use does not establish the safety of unsupervised use.[5]
What it means for you today
Correcting a deficiency is a different question from treating MS. Sadatpour et al. (2026), PMID 42825902, tested vitamin D and curcumin on blood cells from people with MS in the laboratory; this shows no benefit in people.[6] Discuss any supplement and testing with your neurologist. Never stop or change prescribed treatment on your own.
The Coimbra protocol
In plain words: The complete Coimbra protocol has no verified controlled MS benefit, and very high vitamin D can harm the kidneys.
No controlled studies in MS
What is claimed
Very high vitamin D intake controls MS, and restricting calcium makes the protocol safe.
What human studies show
- No controlled study of the complete Coimbra protocol was identified in this search. A retrospective series included 319 people with different autoimmune diseases, 74 of them with MS. It examined calcium and kidney laboratory measurements in selected, monitored patients, without a control group or an MS efficacy endpoint. Normal group averages do not establish individual safety or disease control.[7]
- Two case reports describe high calcium and kidney injury after very high vitamin D exposure in people with MS. They cannot measure how often this occurs, and exact adherence to every part of the named protocol was not established.[8], [9]
Risks
High calcium and kidney injury are documented risks of excessive vitamin D. The protocol's dietary restrictions and repeated laboratory checks also create a burden; whether those restrictions prevent toxicity is unestablished.[5], [7], [8], [9]
What it means for you today
A monitored case series is neither proof of effectiveness nor a guarantee of safety. Discuss claims or supplements with your neurologist. Never stop or change prescribed treatment on your own.
Diets: ketogenic, Wahls, Swank, fasting and Mediterranean-style
In plain words: No studied diet has been shown to stop MS, though food choices may help wellbeing or symptoms.
Randomised trials with mixed results
What is claimed
A particular diet can switch off inflammation, repair myelin or stop MS progression.
What human studies show
- A Cochrane review found varied, low or very low certainty evidence, without reliable proof that a particular diet changes MS. Its search ended in 2019; later trials are separate.[10]
- The NAMS trial randomised 105 people with relapsing MS; 81 completed 18 months. Neither ketogenic nor fasting diets beat a standard healthy diet on the main goal: fewer new lesions on MRI.[11]
- WAVES compared Wahls with Swank in 87 people. On the primary measure, fatigue severity at 12 weeks, both groups improved without a significant difference between them. There was no usual-diet group, so the shared improvement cannot confidently be attributed to the specific diets.[12]
- A ketogenic study without a comparison group enrolled 65 people to test adherence and tolerability; symptom findings were exploratory. A modified Mediterranean programme in 36 women was a feasibility pilot; its fatigue and disability findings do not confirm slower progression.[13], [14]
Risks
Restrictive diets can make adequate nutrition difficult and add cost or social burdens. Gastrointestinal symptoms and menstrual changes were reported in the ketogenic intervention; supported trial settings do not represent unsupervised use.[13], [15]
What it means for you today
Food choices may support wellbeing or some symptoms; these studies do not show that a diet stops MS progression. Discuss major diet changes with your neurologist. Never stop or change prescribed treatment on your own.
Vitamins B and K: B12, high-dose biotin and K2
In plain words: Correct B12 deficiency; the large biotin trial showed no MS benefit, and K2 has no proven MS treatment effect.
The large biotin trial showed no benefit; B12 helps when deficient
What is claimed
B vitamins rebuild nerves, high-dose biotin reverses progressive MS, and K2 repairs myelin, makes high vitamin D intake safe or helps the body absorb B12.
What human studies show
- B12 deficiency can cause neurological problems, even without anaemia. Correcting a deficiency addresses that condition; extra B12 in a person with adequate levels has no demonstrated MS treatment benefit.[16], [15]
- In progressive MS, the initial randomised MS-SPI trial found improvement in disability, its main goal, in 13/103 (12.6%) taking biotin versus 0/51 on placebo. The much larger SPI2 trial did not confirm benefit: 39/326 (12%) versus 29/316 (9%) met its main goal, with no significant difference.[17], [18]
- A comparison of 45 people with MS and 29 controls found lower K2 levels in the MS group. It assigned no K2 treatment and cannot show that K2 changes MS or prevents vitamin D toxicity.[19]
- K2 is also promoted for better B12 absorption. Stomach acid helps release B12 bound to food proteins, and intrinsic factor, a protein made in the stomach, then helps the body absorb it; B12 in supplements is already in free form. Vitamin K helps make proteins involved in blood clotting and bone metabolism. No study showing that K2 improves B12 absorption was identified in this search.[16], [20]
Risks
High-dose biotin can distort laboratory results, including some tests used to detect heart injury. Vitamin K interacts with warfarin and other vitamin K antagonists. B12 deficiency should not be missed by automatically attributing neurological symptoms to MS.[21], [20], [16]
What it means for you today
These are three different questions; the larger biotin trial was negative. Discuss deficiencies and supplements with your neurologist. Never stop or change prescribed treatment on your own.
Other supplements: omega-3, curcumin and probiotics
In plain words: Omega-3, curcumin and probiotics have not shown clear MS treatment benefit in these human studies.
Small or early human studies, no clear benefit shown
What is claimed
Natural anti-inflammatory supplements or changes to gut bacteria can control MS or repair damage.
What human studies show
- The controlled OFAMS trial in 92 people with relapsing MS found no significant omega-3 benefit on the study's main goal, MRI lesions during the first six months; clinical results showed no benefit either.[22]
- The placebo-controlled CONTAIN study randomised 80 people with active relapsing MS. Curcumin added to interferon did not reduce new or enlarging lesions on MRI, its main goal, over 24 months. A smaller study in 50 people reported inflammatory blood-marker changes; these are preliminary findings, not proof of disease control.[23], [24]
- A probiotic trial randomised 70 people and analysed 65; reported results concerned inflammatory markers, not fewer relapses or less disability. A frequently cited separate probiotic paper was retracted and is excluded from efficacy evidence.[25], [26]
Risks
Omega-3 supplements can cause gastrointestinal effects and interact with anticoagulant treatment. Concentrated curcumin supplements can cause gastrointestinal effects and reported liver injury. Probiotic infection risk is greater in severely ill or immunocompromised people; this does not mean everyone with MS is immunocompromised.[27], [28], [29]
What it means for you today
A change in a blood marker is not evidence of fewer relapses, less disability or repaired myelin. Discuss supplements and possible interactions with your neurologist. Never stop or change prescribed treatment on your own.
Unproven stem-cell clinics are covered in the treatment guide. →
Sources
- Munger et al., observational vitamin D study (2006)
- D-Lay MS, JAMA (2025)
- VIDAMS (2023)
- SOLAR (2019)
- NIH, vitamin D fact sheet
- Sadatpour et al. (2026), PMID 42825902
- Amon et al., Coimbra safety series (2022)
- De Vincentis et al., case report (2021)
- Feige et al., case report (2018)
- Cochrane, dietary interventions (2020)
- NAMS, Bahr et al. (2025)
- WAVES, Wahls and Swank (2021)
- Brenton et al., ketogenic pilot (2022)
- Katz Sand et al., Mediterranean-style pilot (2019)
- MS Society UK, Diet and MS (2024)
- NIH, vitamin B12 fact sheet
- MS-SPI, Tourbah et al. (2016)
- SPI2, Cree et al. (2020)
- Lasemi et al., vitamin K2 comparison (2018)
- NIH, vitamin K fact sheet
- FDA, biotin assay interference guidance (2020)
- OFAMS, omega-3 trial (2012)
- CONTAIN, Petracca et al. (2021)
- Dolati et al., nanocurcumin study (2018)
- Rahimlou et al., probiotics trial (2022)
- Retraction of Kouchaki et al. (2025)
- NIH, omega-3 fact sheet
- NCCIH, turmeric safety
- NCCIH, probiotics safety